Medical devices, healthcare technology and the business of care
510(k) clearance · K262346

CureLight Medical Diode Laser Systems (S3-BF45);CureLight Medical Diode Laser Systems (S2-B30);CureLight Medical Diode Laser Systems (S3-BF30);CureLight Medical Diode Laser Systems (S2-F15);CureLight Medical Diode Laser Systems (S2-H7.5)

Wuhan Phomed Technology Co., Ltd. · Decision date Oct 8, 2026

MEDTECHLEDGER EXPLANATIONK262346

What did the FDA decide?

FDA recorded a substantially equivalent decision for K262346 on 2026-10-08, covering the CureLight Medical Diode Laser Systems under five model designations: S3-BF45, S2-B30, S3-BF30, S2-F15 and S2-H7.5. The applicant is Wuhan Phomed Technology Co., Ltd. of Wuhan, China. The submission is a traditional 510(k) filed under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty, and the public record lists the device classification as Powered Laser Surgical Instrument.

Substantially equivalent means FDA cleared the submission as a 510(k); it is not a premarket approval of the device. The record shows the application was received on 07/10/2026 and decided on 10/08/2026, and that it was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The record does not state which predicate device was used, what testing supported equivalence, or what indications the cleared systems carry; those details would sit in the underlying 510(k) documents rather than this summary page.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 8, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262346
Regulatory pathway
510(k) premarket notification
Product code
GEX
Decision code
SESE
Decision date
Oct 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powered Laser Surgical Instrument.

Product code
GEX
FDA device class
2

FDA decision timeline

  1. K262346 received

    Application receipt date recorded by FDA.

  2. K262346 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Wuhan Phomed Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Wuhan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records